Search for Clinical Trial Results

Sponsored By

Duchenne Muscular Dystrophy - 30 Studies Found

Status Study
Terminated Study Name: Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Date: 2014-12-22
Interventions:
  • Drug: PRO044 SC 6 mg/kg
  • Drug: PRO044 IV 6

Completed Study Name: Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Date: 2005-09-08
Interventions: Drug: AVI-4658 (PMO) morpholino antisense oligonucleotide
Terminated Study Name: Phase IIb Study of PRO045 in Subjects With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Date: 2013-03-20
Interventions:
  • Drug: PRO045, 0.15 mg/kg/week

Completed Study Name: L-citrulline and Metformin in Duchenne's Muscular Dystrophy
Condition: Duchenne's Muscular Dystrophy (DMD)
Date: 2013-11-20
Interventions:
  • Drug: 750 mg metformin and 7.5 g L-citrulline daily p.o.
Completed Study Name: DART Electrical Impedance Myography (EIM) Trial in Duchenne Muscular Dystrophy (DMD) and Healthy Controls
Condition: Duchenne Muscular Dystrophy
Date: 2012-01-30
Interventions: Other: Testing with EIM
Completed Study Name: Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)
Condition: Duchenne Muscular Dystrophy
Date: 2008-09-23
Interventions: Drug: Idebenone Patients ≤ 45 kg: 450 mg/day (1 tablet 3 times a day) Patients > 45 kg: 900 mg/